Form 4 holding
Director
Raphael Pharmaceutical Inc.
- Security class
- Common Stock
- Shares / value
- 280,000
- Estimated value
- $140,000
- Report date
- 26 Jul 2022
- Price
- $0.5000
- Ownership
- Direct
Joseph Press - Director at Raphael Pharmaceutical Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- RAPH on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Joseph Press since 04 Aug 2025
Reported holdings for Joseph Press in Raphael Pharmaceutical Inc.
Form 4 holding
Director
Raphael Pharmaceutical Inc.
- Security class
- Warrants to Purchase Common Stock
- Shares / value
- 105,000
- Estimated value
- Report date
- 05 Dec 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Joseph Press in Raphael Pharmaceutical Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.